Gab2 expression in glioma and its implications for tumor invasion

Acta Oncologica

Volumn 52, Issue 8, 2013, Pages 1739-1750

  Shi, Lihong ^a,b   Sun, Xiuning ^b   Zhang, Jin ^b   Zhao, Chunling ^b   Li, Hongli ^b   Liu, Zhijun ^b   Fang, Chunyan ^b   Wang, Xuejian ^b   Zhao, Chunzhen ^b   Zhang, Xiurong ^b   Zhou, Fenghua ^b   Lu, Shijun ^b   Luo, Rongcheng ^a   Zhang, Baogang ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GRB2 ASSOCIATED BINDER 2 PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; SCAFFOLD PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; F ACTIN; GRB2 ASSOCIATED BINDER 2; PROTEIN; SOMATOMEDIN C;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TISSUE; CANCER CELL CULTURE; CANCER GROWTH; CANCER SURVIVAL; CELL MIGRATION; CONTROLLED STUDY; CYTOSKELETON; FEMALE; GENE SILENCING; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SURVIVAL TIME; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; CANCER CELL LINE; CANCER PROGNOSIS; CELL INVASION; DISEASE ASSOCIATION; ENZYME PHOSPHORYLATION; HISTOLOGY; MOLECULAR MECHANICS; OVERALL SURVIVAL; TUMOR GROWTH; VERY ELDERLY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CHEMOTAXIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIOMA; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICE; MICE, SCID; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 84885446637     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.750032     Document Type: Article

References (34)

1. Butowski NA, Sneed PK, Chang SM. Diagnosis and treatment of recurrent high-grade astrocytoma. J Clin Oncol 2006; 24: 1273-80.
2. Nishida K, Hirano T. The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors. Cancer Sci 2003; 94: 1029-33.
3. Hibi M, Hirano T. Gab-family adapter molecules in signal transduction of cytokine and growth factor receptors, and T and B cell antigen receptors. Leuk Lymphoma 2000; 37: 299-307.
4. Gu H, Neel BG. The "Gab" in signal transduction. Trends Cell Biol 2003; 13: 122-30.
5. Wohrle FU, Daly RJ, Brummer T. Function, regulation and pathological roles of the Gab/DOS docking proteins. Cell Commun Signal 2009; 7: 22.
6. Bocanegra M, Bergamaschi A, Kim YH, Miller MA, Rajput AB, Kao J, et al. Focal amplification and oncogene dependency of GAB2 in breast cancer. Oncogene 2010; 29: 774-9.
7. Wang Y, Sheng Q, Spillman MA, Behbakht K, Gu H. Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells. Oncogene 2012; 31: 2512-20.
8. Horst B, Gruvberger-Saal SK, Hopkins BD, Bordone L, Yang Y, Chernoff KA, et al. Gab2-mediated signaling promotes melanoma metastasis. Am J Pathol 2009; 174: 1524-33.
9. Lee SH, Jeong EG, Nam SW, Lee JY, Yoo NJ, Lee SH. Increased expression of Gab2, a scaffolding adaptor of the tyrosine kinase signalling, in gastric carcinomas. Pathology 2007; 39: 326-9.
10. Xu XL, Wang X, Chen ZL, Jin M, Yang W, Zhao GF, et al. Overexpression of Grb2-associated binder 2 in human lung cancer. Int J Biol Sci 2011; 7: 496-504.
11. Zatkova A, Schoch C, Speleman F, Poppe B, Mannhalter C, Fonatsch C, et al. GAB2 is a novel target of 11q amplification in AML/MDS. Genes Chromosomes Cancer 2006; 45: 798-807.
12. El-Habr EA, Tsiorva P, Theodorou M, Levidou G, Korkolopoulou P, Vretakos G, et al. Analysis of PIK3CA and B-RAF gene mutations in human astrocytomas: Association with activation of ERK and AKT. Clin Neuropathol 2010; 29: 239-45.
13. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 2000; 89: 2637-45.
14. Zhang B, Gu F, She C, Guo H, Li W, Niu R, et al. Reduction of Akt2 inhibits migration and invasion of glioma cells. Int J Cancer 2009; 125: 585-95.
15. Zhang B, Ma Y, Guo H, Sun B, Niu R, Ying G, et al. Akt2 is required for macrophage chemotaxis. Eur J Immunol 2009; 39: 894-901.
16. Takino T, Nakada M, Miyamori H, Yamashita J, Yamada KM, Sato H. CrkI adapter protein modulates cell migration and invasion in glioblastoma. Cancer Res 2003; 63: 2335-7.
17. Liu L, W u J, Ying Z, Chen B, Han A, Liang Y, et al. Astrocyte elevated gene-1 up-regulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Res 2010; 70: 3750-9.
18. Clemmons DR. Modifying IGF1 activity: An approach to treat endocrine disorders, atherosclerosis and cancer. Nat Rev Drug Discov 2007; 6: 821-33.
19. Miller BS, Ye e D. Type I insulin-like growth factor receptor as a therapeutic target in cancer. Cancer Res 2005; 65: 10123-7.
20. Xavier CP, Rastetter RH, Blömacher M, Stumpf M, Himmel M, Morgan RO, et al. Phosphorylation of CRN2 by CK2 regulates F-actin and Arp2/3 interaction and inhibits cell migration. Sci Rep 2012; 2: 241.
21. Wang N, Feng Y, Lau EP, Tsang C, Ching Y, Man K, et al. F-actin reorganization and inactivation of rho signaling pathway involved in the inhibitory effect of Coptidis Rhizoma on hepatoma cell migration. Integr Cancer Ther 2010; 9: 354-64.
22. Bernard O. Lim kinases, regulators of actin dynamics. Int J Biochem Cell Biol 2007; 39: 1071-6.
23. Sun ZF, Wang L, Gu F, Fu L, Li WL, Ma YJ. [Expression of Notch1, MMP-2 and MMP-9 and their significance in glioma patients]. Zhonghua Zhong Liu Za Zhi 2012; 34: 26-30.
24. Toker A, Yoeli-Lerner M. Akt signaling and cancer: Surviving but not moving on. Cancer Res 2006; 66: 3963-6.
25. Bibollet-Bahena O, Almazan G. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways. J Neurochem 2009; 109: 1440-51.
26. Y u J, Li J, Zhang S, Xu X, Zheng M, Jiang G, et al. IGF-1 induces hypoxia-inducible factor 1alpha-mediated GLUT3 expression through PI3K/Akt/mTOR dependent pathways in PC12 cells. Brain Res 2012; 1430: 18-24.
27. Jiang H, Shang X, Wu H, Gautam SC, Al-Holou S, Li C, et al. Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells. J Exp Ther Oncol 2009; 8: 25-33.
28. Yan B, Kong M, Chen S, Chen YH. VEGF stimulation enhances Livin protein synthesis through mTOR signaling. J Cell Biochem 2010; 111: 1114-24.
29. Tran TT, Uhl M, Ma JY, Janssen L, Sriram V, Aulwurm S, et al. Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model. Neuro Oncol 2007; 9: 259-70.
30. Esteve PO, Tremblay P, Houde M, St-Pierre Y, Mandeville R. In vitro expression of MMP-2 and MMP-9 in glioma cells following exposure to infl ammatory mediators. Biochim Biophys Acta 1998; 1403: 85-96.
31. Chien CS, Shen KH, Huang JS, Ko SC, Shih YW. Antimetastatic potential of fisetin involves inactivation of the PI3K/Akt and JNK signaling pathways with downregulation of MMP-2/9 expressions in prostate cancer PC-3 cells. Mol Cell Biochem 2010; 333: 169-80.
32. Chinni SR, Sivalogan S, Dong Z, Filho JC, Deng X, Bonfil RD, et al. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: The role of bone microen-vironment-associated CXCL12. Prostate 2006; 66: 32-48.
33. Chetty C, Lakka SS, Bhoopathi P, Rao JS. MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells. Int J Cancer 2010; 127: 1081-95.
34. Zhang D, Brodt P. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling. Oncogene 2003; 22: 974-82.